Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance
about
Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.Therapeutic strategies for chemotherapy-induced neutropenia in patients with solid tumors.Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunityThe prevention and management of infections due to multidrug resistant organisms in haematology patientsTackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms.Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol - a prospective nationwide study.Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia.Sparing carbapenem usage.Prophylactic levofloxacin in pediatric neutropenic patients during autologous hematopoietic stem cell transplantation.Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study.Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia.Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.
P2860
Q30238945-B9E32D0E-1CA5-49FE-9D62-68BE370D37ECQ30252749-EB211CAD-EF77-4202-8C98-C2024E15720DQ34175284-232D2355-397A-4F66-B7D8-A5240309FDC7Q34670717-2C981207-8D6B-4F04-BD32-48E79AB2ABE4Q35677483-6DC1E25F-A111-4DD1-9D4A-2934E4B80835Q38171538-04F52B18-3AFB-44A5-B254-CEDD4D2843B5Q38538705-09F5D3E3-FA6F-4352-8AD9-BA9BFC3E1C6AQ38690746-F429B62C-84E4-4925-8B8E-71C7561FE196Q38703330-2371D9BF-8661-41DC-A699-DA742FD5EF4EQ38839812-D166059E-5BEA-4893-8AF6-E357F678717CQ39388468-C2800ECA-8265-4889-BD83-69F68D0EC882Q40139724-B9313544-71D2-43FF-87A6-187C78201863Q40734670-D4EB7341-043B-4044-9EFD-4A0E6FA19930Q41993143-E8B48FBC-2A49-465D-99BD-32EC711365E3Q50119378-0A6D285C-EA39-4264-82AF-5A53921B2E7B
P2860
Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Ciprofloxacin prophylaxis in h ...... crobial therapy and resistance
@ast
Ciprofloxacin prophylaxis in h ...... crobial therapy and resistance
@en
type
label
Ciprofloxacin prophylaxis in h ...... crobial therapy and resistance
@ast
Ciprofloxacin prophylaxis in h ...... crobial therapy and resistance
@en
prefLabel
Ciprofloxacin prophylaxis in h ...... crobial therapy and resistance
@ast
Ciprofloxacin prophylaxis in h ...... crobial therapy and resistance
@en
P2093
P2860
P356
P1476
Ciprofloxacin prophylaxis in h ...... crobial therapy and resistance
@en
P2093
Angelo Maiolino
Beatriz M Moreira
Flávia L P C Pellegrino
Simone A Nouér
P2860
P2888
P356
10.1186/1471-2334-13-356
P577
2013-07-31T00:00:00Z